Profil
Matthew Panuwat is currently Chief Business Officer at Oric Pharmaceuticals, Inc., a position held since 2018.
Formerly, Mr. Panuwat was Head of Business Development at Medivation LLC (California) and Senior Vice President of Business Development at Prothena Corp.
Plc from 2017 to 2018.
Education includes an MBA from the University of California, Los Angeles, an undergraduate degree from Santa Clara University, and graduate studies at Georgetown University.
Aktive Positionen von Matthew Panuwat
| Unternehmen | Position | Beginn |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.11.2018 |
Ehemalige bekannte Positionen von Matthew Panuwat
| Unternehmen | Position | Ende |
|---|---|---|
| PROTHENA CORPORATION PLC | Corporate Officer/Principal | 01.11.2018 |
| MEDIVATION INC | Corporate Officer/Principal | - |
Ausbildung von Matthew Panuwat
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Prothena Corp. Plc
Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
















